Search

Author/Creator Fedler, Janel

1. Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study. (26th January 2021)

Authors:
Naismith, Robert T.; Bermel, Robert A.; Coffey, Christopher S.; Goodman, Andrew D.; Fedler, Janel; Kearney, Marianne; Klawiter, Eric C.; Nakamura, Kunio; Narayanan, Sridar; Goebel, Christopher; Yankey, Jon; Klingner, Elizabeth; Fox, Robert J.; Shinnar, Shlomo; Ontaneda, Daniel; Riley, Claire S.; ...
Journal:
Neurology
Issue:
Volume 96:Number 4(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease. Issue 3 (2nd July 2020)

Authors:
Irwin, David J.; Fedler, Janel; Coffey, Christopher S.; Caspell‐Garcia, Chelsea; Kang, Ju Hee; Simuni, Tanya; Foroud, Tatiana; Toga, Arthur W.; Tanner, Caroline M.; Kieburtz, Karl; Chahine, Lana M.; Reimer, Alyssa; Hutten, Samantha; Weintraub, Daniel; Mollenhauer, Brit; Galasko, Douglas R.; Sider...
Journal:
Annals of neurology
Issue:
Volume 88:Issue 3(2020)
Page Start:
574
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis. (5th December 2022)

Authors:
Wong, Ka-Ho; Day, Gregory; Titulaer, Maarten; Torner, James; Cudkowicz, Merit; Coffey, Christopher; Lungu, Codrin; Klawiter, Eric; Singleton, J.; Mitchell, Dana; Fedler, Janel; Ecklund, Dixie; Klements, David; Costigan, Michele; Clardy, Stacey
Journal:
Neurology
Issue:
Volume 99:Number 23(2022)Supplement 2
Page Start:
S39
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis. (5th December 2022)

Authors:
Wong, Ka-Ho; Day, Gregory; Titulaer, Maarten; Torner, James; Cudkowicz, Merit; Coffey, Christopher; Lungu, Codrin; Klawiter, Eric; Singleton, J.; Mitchell, Dana; Fedler, Janel; Ecklund, Dixie; Klements, David; Costigan, Michele; Clardy, Stacey
Journal:
Neurology
Issue:
Volume 99:Number 23(2022)Supplement 2
Page Start:
S39
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis. (5th December 2022)

Authors:
Wong, Ka-Ho; Day, Gregory; Titulaer, Maarten; Torner, James; Cudkowicz, Merit; Coffey, Christopher; Lungu, Codrin; Klawiter, Eric; Singleton, J.; Mitchell, Dana; Fedler, Janel; Ecklund, Dixie; Klements, David; Costigan, Michele; Clardy, Stacey
Journal:
Neurology
Issue:
Volume 99:Number 23(2022)Supplement 2
Page Start:
S39
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis. (5th December 2022)

Authors:
Wong, Ka-Ho; Day, Gregory; Titulaer, Maarten; Torner, James; Cudkowicz, Merit; Coffey, Christopher; Lungu, Codrin; Klawiter, Eric; Singleton, J.; Mitchell, Dana; Fedler, Janel; Ecklund, Dixie; Klements, David; Costigan, Michele; Clardy, Stacey
Journal:
Neurology
Issue:
Volume 99:Number 23(2022)Supplement 2
Page Start:
S39
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗